Patent · US Active

Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptor

US9732087B2 · kind B2 · utility

0Cited by

13References

21Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Hui Cai · San Diego, US
Frank Chavez · San Diego, US
Paul J. Dunford · Solana Beach, US
Andrew J. Greenspan · San Diego, US
Steven P. Meduna · San Diego, US
Jorge A. Quiroz · Princeton, US
Brad M. Savall · San Diego, US
Kevin L. Tays · Irvine, US
Robin Thurmond · San Diego, US
Jianmei Wei · Town of East Hartford, US
Ronald L. Wolin · San Diego, US
Xiaohu Zhang · Suzhou, CN

Key dates

Filing date	Aug 14, 2014
Grant date	Aug 15, 2017
Priority date	—
Expiry date	Dec 12, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Diamino-pyridine, pyrimidine and pyridazine compounds which may be used as H4 receptor modulators, and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.